The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Parenteral Formula Market Research Report 2025
Synopsis
Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
The global Parenteral Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Parenteral Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parenteral Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Parenteral Formula include Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co.,Ltd., Grifols, S.A., Aculife Healthcare Private Limited, Vifor Pharma Group, Terumo Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Formula.
The Parenteral Formula market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Parenteral Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter International lnc.
B.Braun Melsungen AG
Fresenius Kabi AG
Hospira, Inc.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co.,Ltd.
Grifols, S.A.
Aculife Healthcare Private Limited
Vifor Pharma Group
Terumo Corporation
Nutricia
Segment by Type
Carbohydrates
Amino Acids
Lipids
Electrolytes
Vitamins and Minerals
Specialty Formulas
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parenteral Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parenteral Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Parenteral formulas are specialized liquid formulations administered intravenously to provide essential nutrients and fluids to individuals who are unable to obtain adequate nutrition through oral or enteral routes. Parenteral formulas are typically prescribed for patients with severe gastrointestinal disorders, malabsorption syndromes, or other medical conditions that impair their ability to absorb nutrients from food.
The global Parenteral Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Parenteral Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parenteral Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Parenteral Formula include Baxter International lnc., B.Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Sichuan Kelun Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co.,Ltd., Grifols, S.A., Aculife Healthcare Private Limited, Vifor Pharma Group, Terumo Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Parenteral Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Formula.
The Parenteral Formula market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Parenteral Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter International lnc.
B.Braun Melsungen AG
Fresenius Kabi AG
Hospira, Inc.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical Co.,Ltd.
Grifols, S.A.
Aculife Healthcare Private Limited
Vifor Pharma Group
Terumo Corporation
Nutricia
Segment by Type
Carbohydrates
Amino Acids
Lipids
Electrolytes
Vitamins and Minerals
Specialty Formulas
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parenteral Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parenteral Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Parenteral Formula Market Overview
1.1 Product Definition
1.2 Parenteral Formula by Type
1.2.1 Global Parenteral Formula Market Value Comparison by Type (2024-2030)
1.2.2 Carbohydrates
1.2.3 Amino Acids
1.2.4 Lipids
1.2.5 Electrolytes
1.2.6 Vitamins and Minerals
1.2.7 Specialty Formulas
1.3 Parenteral Formula by Application
1.3.1 Global Parenteral Formula Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Parenteral Formula Market Size Estimates and Forecasts
1.4.1 Global Parenteral Formula Revenue 2019-2030
1.4.2 Global Parenteral Formula Sales 2019-2030
1.4.3 Global Parenteral Formula Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Parenteral Formula Market Competition by Manufacturers
2.1 Global Parenteral Formula Sales Market Share by Manufacturers (2019-2024)
2.2 Global Parenteral Formula Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Parenteral Formula Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Parenteral Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Formula, Product Type & Application
2.7 Global Key Manufacturers of Parenteral Formula, Date of Enter into This Industry
2.8 Global Parenteral Formula Market Competitive Situation and Trends
2.8.1 Global Parenteral Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Parenteral Formula Players Market Share by Revenue
2.8.3 Global Parenteral Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral Formula Market Scenario by Region
3.1 Global Parenteral Formula Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Parenteral Formula Sales by Region: 2019-2030
3.2.1 Global Parenteral Formula Sales by Region: 2019-2024
3.2.2 Global Parenteral Formula Sales by Region: 2025-2030
3.3 Global Parenteral Formula Revenue by Region: 2019-2030
3.3.1 Global Parenteral Formula Revenue by Region: 2019-2024
3.3.2 Global Parenteral Formula Revenue by Region: 2025-2030
3.4 North America Parenteral Formula Market Facts & Figures by Country
3.4.1 North America Parenteral Formula Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Parenteral Formula Sales by Country (2019-2030)
3.4.3 North America Parenteral Formula Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Parenteral Formula Market Facts & Figures by Country
3.5.1 Europe Parenteral Formula Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Parenteral Formula Sales by Country (2019-2030)
3.5.3 Europe Parenteral Formula Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Formula Market Facts & Figures by Region
3.6.1 Asia Pacific Parenteral Formula Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Parenteral Formula Sales by Region (2019-2030)
3.6.3 Asia Pacific Parenteral Formula Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Parenteral Formula Market Facts & Figures by Country
3.7.1 Latin America Parenteral Formula Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Parenteral Formula Sales by Country (2019-2030)
3.7.3 Latin America Parenteral Formula Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Parenteral Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Formula Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Parenteral Formula Sales by Country (2019-2030)
3.8.3 Middle East and Africa Parenteral Formula Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Parenteral Formula Sales by Type (2019-2030)
4.1.1 Global Parenteral Formula Sales by Type (2019-2024)
4.1.2 Global Parenteral Formula Sales by Type (2025-2030)
4.1.3 Global Parenteral Formula Sales Market Share by Type (2019-2030)
4.2 Global Parenteral Formula Revenue by Type (2019-2030)
4.2.1 Global Parenteral Formula Revenue by Type (2019-2024)
4.2.2 Global Parenteral Formula Revenue by Type (2025-2030)
4.2.3 Global Parenteral Formula Revenue Market Share by Type (2019-2030)
4.3 Global Parenteral Formula Price by Type (2019-2030)
5 Segment by Application
5.1 Global Parenteral Formula Sales by Application (2019-2030)
5.1.1 Global Parenteral Formula Sales by Application (2019-2024)
5.1.2 Global Parenteral Formula Sales by Application (2025-2030)
5.1.3 Global Parenteral Formula Sales Market Share by Application (2019-2030)
5.2 Global Parenteral Formula Revenue by Application (2019-2030)
5.2.1 Global Parenteral Formula Revenue by Application (2019-2024)
5.2.2 Global Parenteral Formula Revenue by Application (2025-2030)
5.2.3 Global Parenteral Formula Revenue Market Share by Application (2019-2030)
5.3 Global Parenteral Formula Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter International lnc.
6.1.1 Baxter International lnc. Company Information
6.1.2 Baxter International lnc. Description and Business Overview
6.1.3 Baxter International lnc. Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter International lnc. Parenteral Formula Product Portfolio
6.1.5 Baxter International lnc. Recent Developments/Updates
6.2 B.Braun Melsungen AG
6.2.1 B.Braun Melsungen AG Company Information
6.2.2 B.Braun Melsungen AG Description and Business Overview
6.2.3 B.Braun Melsungen AG Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B.Braun Melsungen AG Parenteral Formula Product Portfolio
6.2.5 B.Braun Melsungen AG Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Company Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi AG Parenteral Formula Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Hospira, Inc.
6.4.1 Hospira, Inc. Company Information
6.4.2 Hospira, Inc. Description and Business Overview
6.4.3 Hospira, Inc. Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hospira, Inc. Parenteral Formula Product Portfolio
6.4.5 Hospira, Inc. Recent Developments/Updates
6.5 Sichuan Kelun Pharmaceutical Co.,Ltd.
6.5.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
6.5.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
6.5.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolio
6.5.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.6 Otsuka Pharmaceutical Co.,Ltd.
6.6.1 Otsuka Pharmaceutical Co.,Ltd. Company Information
6.6.2 Otsuka Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product Portfolio
6.6.5 Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Grifols, S.A.
6.7.1 Grifols, S.A. Company Information
6.7.2 Grifols, S.A. Description and Business Overview
6.7.3 Grifols, S.A. Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Grifols, S.A. Parenteral Formula Product Portfolio
6.7.5 Grifols, S.A. Recent Developments/Updates
6.8 Aculife Healthcare Private Limited
6.8.1 Aculife Healthcare Private Limited Company Information
6.8.2 Aculife Healthcare Private Limited Description and Business Overview
6.8.3 Aculife Healthcare Private Limited Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aculife Healthcare Private Limited Parenteral Formula Product Portfolio
6.8.5 Aculife Healthcare Private Limited Recent Developments/Updates
6.9 Vifor Pharma Group
6.9.1 Vifor Pharma Group Company Information
6.9.2 Vifor Pharma Group Description and Business Overview
6.9.3 Vifor Pharma Group Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vifor Pharma Group Parenteral Formula Product Portfolio
6.9.5 Vifor Pharma Group Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Company Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Terumo Corporation Parenteral Formula Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
6.11 Nutricia
6.11.1 Nutricia Company Information
6.11.2 Nutricia Description and Business Overview
6.11.3 Nutricia Parenteral Formula Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nutricia Parenteral Formula Product Portfolio
6.11.5 Nutricia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Formula Industry Chain Analysis
7.2 Parenteral Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Formula Production Mode & Process
7.4 Parenteral Formula Sales and Marketing
7.4.1 Parenteral Formula Sales Channels
7.4.2 Parenteral Formula Distributors
7.5 Parenteral Formula Customers
8 Parenteral Formula Market Dynamics
8.1 Parenteral Formula Industry Trends
8.2 Parenteral Formula Market Drivers
8.3 Parenteral Formula Market Challenges
8.4 Parenteral Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Parenteral Formula Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Parenteral Formula Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Parenteral Formula Market Competitive Situation by Manufacturers in 2023
Table 4. Global Parenteral Formula Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Parenteral Formula Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Parenteral Formula Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Parenteral Formula Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Parenteral Formula Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Parenteral Formula, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Parenteral Formula, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Parenteral Formula, Product Type & Application
Table 12. Global Key Manufacturers of Parenteral Formula, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Parenteral Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Formula as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Parenteral Formula Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Parenteral Formula Sales by Region (2019-2024) & (K Units)
Table 18. Global Parenteral Formula Sales Market Share by Region (2019-2024)
Table 19. Global Parenteral Formula Sales by Region (2025-2030) & (K Units)
Table 20. Global Parenteral Formula Sales Market Share by Region (2025-2030)
Table 21. Global Parenteral Formula Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Parenteral Formula Revenue Market Share by Region (2019-2024)
Table 23. Global Parenteral Formula Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Parenteral Formula Revenue Market Share by Region (2025-2030)
Table 25. North America Parenteral Formula Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 27. North America Parenteral Formula Sales by Country (2025-2030) & (K Units)
Table 28. North America Parenteral Formula Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Parenteral Formula Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Parenteral Formula Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 32. Europe Parenteral Formula Sales by Country (2025-2030) & (K Units)
Table 33. Europe Parenteral Formula Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Parenteral Formula Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Parenteral Formula Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Parenteral Formula Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Parenteral Formula Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Parenteral Formula Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Parenteral Formula Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Parenteral Formula Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Parenteral Formula Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Parenteral Formula Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Parenteral Formula Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Parenteral Formula Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Parenteral Formula Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Parenteral Formula Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Parenteral Formula Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Parenteral Formula Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Parenteral Formula Sales (K Units) by Type (2019-2024)
Table 51. Global Parenteral Formula Sales (K Units) by Type (2025-2030)
Table 52. Global Parenteral Formula Sales Market Share by Type (2019-2024)
Table 53. Global Parenteral Formula Sales Market Share by Type (2025-2030)
Table 54. Global Parenteral Formula Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Parenteral Formula Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Parenteral Formula Revenue Market Share by Type (2019-2024)
Table 57. Global Parenteral Formula Revenue Market Share by Type (2025-2030)
Table 58. Global Parenteral Formula Price (US$/Unit) by Type (2019-2024)
Table 59. Global Parenteral Formula Price (US$/Unit) by Type (2025-2030)
Table 60. Global Parenteral Formula Sales (K Units) by Application (2019-2024)
Table 61. Global Parenteral Formula Sales (K Units) by Application (2025-2030)
Table 62. Global Parenteral Formula Sales Market Share by Application (2019-2024)
Table 63. Global Parenteral Formula Sales Market Share by Application (2025-2030)
Table 64. Global Parenteral Formula Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Parenteral Formula Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Parenteral Formula Revenue Market Share by Application (2019-2024)
Table 67. Global Parenteral Formula Revenue Market Share by Application (2025-2030)
Table 68. Global Parenteral Formula Price (US$/Unit) by Application (2019-2024)
Table 69. Global Parenteral Formula Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter International lnc. Company Information
Table 71. Baxter International lnc. Description and Business Overview
Table 72. Baxter International lnc. Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter International lnc. Parenteral Formula Product
Table 74. Baxter International lnc. Recent Developments/Updates
Table 75. B.Braun Melsungen AG Company Information
Table 76. B.Braun Melsungen AG Description and Business Overview
Table 77. B.Braun Melsungen AG Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. B.Braun Melsungen AG Parenteral Formula Product
Table 79. B.Braun Melsungen AG Recent Developments/Updates
Table 80. Fresenius Kabi AG Company Information
Table 81. Fresenius Kabi AG Description and Business Overview
Table 82. Fresenius Kabi AG Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Fresenius Kabi AG Parenteral Formula Product
Table 84. Fresenius Kabi AG Recent Developments/Updates
Table 85. Hospira, Inc. Company Information
Table 86. Hospira, Inc. Description and Business Overview
Table 87. Hospira, Inc. Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Hospira, Inc. Parenteral Formula Product
Table 89. Hospira, Inc. Recent Developments/Updates
Table 90. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
Table 91. Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
Table 92. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sichuan Kelun Pharmaceutical Co.,Ltd. Parenteral Formula Product
Table 94. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 95. Otsuka Pharmaceutical Co.,Ltd. Company Information
Table 96. Otsuka Pharmaceutical Co.,Ltd. Description and Business Overview
Table 97. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Otsuka Pharmaceutical Co.,Ltd. Parenteral Formula Product
Table 99. Otsuka Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 100. Grifols, S.A. Company Information
Table 101. Grifols, S.A. Description and Business Overview
Table 102. Grifols, S.A. Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Grifols, S.A. Parenteral Formula Product
Table 104. Grifols, S.A. Recent Developments/Updates
Table 105. Aculife Healthcare Private Limited Company Information
Table 106. Aculife Healthcare Private Limited Description and Business Overview
Table 107. Aculife Healthcare Private Limited Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Aculife Healthcare Private Limited Parenteral Formula Product
Table 109. Aculife Healthcare Private Limited Recent Developments/Updates
Table 110. Vifor Pharma Group Company Information
Table 111. Vifor Pharma Group Description and Business Overview
Table 112. Vifor Pharma Group Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Vifor Pharma Group Parenteral Formula Product
Table 114. Vifor Pharma Group Recent Developments/Updates
Table 115. Terumo Corporation Company Information
Table 116. Terumo Corporation Description and Business Overview
Table 117. Terumo Corporation Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Terumo Corporation Parenteral Formula Product
Table 119. Terumo Corporation Recent Developments/Updates
Table 120. Nutricia Company Information
Table 121. Nutricia Description and Business Overview
Table 122. Nutricia Parenteral Formula Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Nutricia Parenteral Formula Product
Table 124. Nutricia Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Parenteral Formula Distributors List
Table 128. Parenteral Formula Customers List
Table 129. Parenteral Formula Market Trends
Table 130. Parenteral Formula Market Drivers
Table 131. Parenteral Formula Market Challenges
Table 132. Parenteral Formula Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Parenteral Formula
Figure 2. Global Parenteral Formula Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Parenteral Formula Market Share by Type: 2023 & 2030
Figure 4. Carbohydrates Product Picture
Figure 5. Amino Acids Product Picture
Figure 6. Lipids Product Picture
Figure 7. Electrolytes Product Picture
Figure 8. Vitamins and Minerals Product Picture
Figure 9. Specialty Formulas Product Picture
Figure 10. Global Parenteral Formula Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Parenteral Formula Market Share by Application: 2023 & 2030
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Parenteral Formula Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Parenteral Formula Market Size (2019-2030) & (US$ Million)
Figure 17. Global Parenteral Formula Sales (2019-2030) & (K Units)
Figure 18. Global Parenteral Formula Average Price (US$/Unit) & (2019-2030)
Figure 19. Parenteral Formula Report Years Considered
Figure 20. Parenteral Formula Sales Share by Manufacturers in 2023
Figure 21. Global Parenteral Formula Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Parenteral Formula Players: Market Share by Revenue in Parenteral Formula in 2023
Figure 23. Parenteral Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Parenteral Formula Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Parenteral Formula Sales Market Share by Country (2019-2030)
Figure 26. North America Parenteral Formula Revenue Market Share by Country (2019-2030)
Figure 27. United States Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Parenteral Formula Sales Market Share by Country (2019-2030)
Figure 30. Europe Parenteral Formula Revenue Market Share by Country (2019-2030)
Figure 31. Germany Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Parenteral Formula Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Parenteral Formula Revenue Market Share by Region (2019-2030)
Figure 38. China Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Parenteral Formula Sales Market Share by Country (2019-2030)
Figure 46. Mexico Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Parenteral Formula Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Parenteral Formula Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Parenteral Formula Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Parenteral Formula by Type (2019-2030)
Figure 56. Global Revenue Market Share of Parenteral Formula by Type (2019-2030)
Figure 57. Global Parenteral Formula Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Parenteral Formula by Application (2019-2030)
Figure 59. Global Revenue Market Share of Parenteral Formula by Application (2019-2030)
Figure 60. Global Parenteral Formula Price (US$/Unit) by Application (2019-2030)
Figure 61. Parenteral Formula Value Chain
Figure 62. Parenteral Formula Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
